Related Experiment Video
Updated: Jul 10, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Hypoxia and cancer
M Christiane Brahimi-Horn1, Johanna Chiche, Jacques Pouysségur
1Institute of Signaling, Developmental Biology and Cancer Research, University of Nice, CNRS UMR 6543, Centre A. Lacassagne, 33 Avenue Valombrose, 06189, Nice, France, brahimi@unice.fr
Journal of Molecular Medicine (Berlin, Germany)
|November 21, 2007
Summary
Solid tumors often feature hypoxia, or low oxygen, which promotes cancer progression and treatment resistance. Understanding cellular responses to hypoxia, particularly the hypoxia-inducible factor, is key to developing new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Solid tumors frequently exhibit hypoxia, a condition of decreased oxygen availability.
- Hypoxia increases resistance to cancer treatments and promotes tumor progression and metastasis.
- Tumor cell proliferation outpaces vascular supply, creating hypoxic microenvironments.
Purpose of the Study:
- To explore the mechanisms of hypoxia generation in tumors.
- To understand cellular responses to hypoxic conditions.
- To define the role of hypoxia signaling in cancer progression and prognosis.
Main Methods:
- Investigating the molecular response to hypoxia.
- Analyzing the activation of hypoxia-inducible factors (HIFs).
- Examining the gene regulatory networks controlled by HIFs in tumor cells.
Main Results:
- Hypoxic conditions activate hypoxia-inducible factors (HIFs) in both normal and neoplastic cells.
- HIFs regulate genes crucial for tumor cell survival, treatment resistance, and nutrient acquisition.
- Hypoxia is a significant factor in cancer progression and treatment failure.
Conclusions:
- Hypoxia is a critical hallmark of solid tumors, driving aggressive behavior and therapeutic challenges.
- Targeting hypoxia-inducible factor signaling pathways may offer novel therapeutic strategies.
- Further research into hypoxia mechanisms is essential for improving cancer treatment efficacy.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...